ArticleCell biology international2026
Cytokeratin Detection in Lymphoid Tumor Cell Lines: Implications for Flow Cytometry and Molecular Analyses.
Article in Cell biology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytokeratins are widely used as epithelial markers in diagnostic pathology and flow cytometry, and malignant lymphomas are generally considered cytokeratin-negative except for undifferentiated large cell lymphomas. During antibody screening experiments using flow cytometry, intracellular cytokeratin signals were unexpectedly detected in cultured lymphoma cell lines after cell permeabilization. Although cytokeratin is a component of the cytoskeleton, this finding raised concerns regarding the interpretation of cytokeratin positivity in lymphoid cells. To elucidate the nature of cytokeratin detection in lymphomas, cultured T-cell, B-cell, and natural killer cell lymphoma lines were analyzed using immunohistochemistry, flow cytometry, and quantitative RT-PCR (qRT-PCR), with epithelial carcinoma cell lines and keratin-free cells as references. Because malignant lymphomas disseminate systemically, we examined whether this behavior was associated with epithelial-mesenchymal transition-like features. Cytokeratins were not detected on the cell surface of lymphoid or epithelial cells but were detected intracellularly in multiple lymphoma cell lines. qRT-PCR confirmed the expression of multiple keratin transcripts in lymphoid cells, without correlation with epithelial-mesenchymal transition-related markers, including CDH1. These findings indicate that intracellular cytokeratin detection can occur in lymphoma cell lines without evidence of epithelial differentiation or association with EMT-related markers and should be considered when interpreting cytokeratin positivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.